Paper
0
A large-scale population-based study reveals that gp42-IgG antibody is protective against Epstein-Barr virus-associated nasopharyngeal carcinoma
Authors
Xiang‐Wei Kong,Guo‐Long Bu
Hua Chen,Yu-Hua Huang,Zhiwei Liu,Yinfeng Kang,yuanfei li,Xia Yu,Biaohua Wu,Ziqian Li,Xinchun Chen,Shang‐Hang Xie,Dong‐Feng Lin,Tong Li,Shumei Yan,Runkun Han,Nan Huang,Qianyu Wang,Zhiyong Li,Ao Zhang,Qian Zhong,Xiao-Ming Huang,Weimin Ye,Mingfang Ji,Yong-Lin Cai,Su-Mei Cao
+24 authors
,Mu‐Sheng ZengPublished
Nov 26, 2024
Show more
Save
Tip0
TipSave
Abstract
BACKGROUND. Epstein-Barr virus (EBV) is associated with nasopharyngeal carcinoma (NPC), but the existence of NPC protective antibody against EBV-associated antigens remains inconclusive.
Paper PDF
This PDF hasn't been uploaded yet.
Do not upload any copyrighted content to the site, only open-access content.
or